News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,011 Results
Type
Article (64090)
Company Profile (127)
Press Release (656794)
Multimedia
Podcasts (101)
Webinars (12)
Section
Business (201242)
Career Advice (3048)
Deals (35267)
Drug Delivery (110)
Drug Development (82677)
Employer Resources (173)
FDA (16414)
Job Trends (15339)
News (345227)
Policy (33647)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (2)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2884)
Academic (2)
Accelerated approval (6)
Adcomms (27)
Allergies (89)
Alliances (50692)
ALS (96)
Alzheimer's disease (1449)
Antibody-drug conjugate (ADC) (126)
Approvals (16405)
Artificial intelligence (282)
Autoimmune disease (26)
Automation (16)
Bankruptcy (325)
Best Places to Work (11837)
BIOSECURE Act (20)
Biosimilars (114)
Biotechnology (85)
Bladder cancer (70)
Brain cancer (28)
Breast cancer (277)
Cancer (2205)
Cardiovascular disease (187)
Career advice (2579)
Career pathing (34)
CAR-T (161)
Cell therapy (445)
Cervical cancer (21)
Clinical research (66892)
Collaboration (847)
Compensation (373)
Complete response letters (22)
COVID-19 (2705)
CRISPR (41)
C-suite (254)
Cystic fibrosis (105)
Data (2111)
Decentralized trials (2)
Denatured (37)
Depression (52)
Diabetes (268)
Diagnostics (6520)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (131)
Drug pricing (111)
Drug shortages (27)
Duchenne muscular dystrophy (93)
Earnings (77310)
Editorial (41)
Employer branding (21)
Employer resources (151)
Events (110337)
Executive appointments (749)
FDA (17668)
Featured Employer (39)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (768)
Gene editing (106)
Generative AI (28)
Gene therapy (313)
GLP-1 (752)
Government (4892)
Grass and pollen (6)
Guidances (51)
Healthcare (19719)
Huntington's disease (20)
IgA nephropathy (25)
Immunology and inflammation (123)
Indications (29)
Infectious disease (2847)
Inflammatory bowel disease (142)
Inflation Reduction Act (10)
Influenza (54)
Intellectual property (95)
Interviews (580)
IPO (16181)
IRA (44)
Job creations (3924)
Job search strategy (2155)
Kidney cancer (10)
Labor market (33)
Layoffs (524)
Leadership (22)
Legal (8052)
Liver cancer (73)
Lung cancer (315)
Lymphoma (147)
Machine learning (6)
Management (59)
Manufacturing (298)
MASH (66)
Medical device (13523)
Medtech (13528)
Mergers & acquisitions (19645)
Metabolic disorders (688)
Multiple sclerosis (81)
NASH (18)
Neurodegenerative disease (94)
Neuropsychiatric disorders (33)
Neuroscience (2010)
NextGen: Class of 2025 (6980)
Non-profit (4894)
Northern California (2477)
Now hiring (19)
Obesity (361)
Opinion (259)
Ovarian cancer (72)
Pain (88)
Pancreatic cancer (80)
Parkinson's disease (153)
Partnered (22)
Patents (238)
Patient recruitment (108)
Peanut (51)
People (61236)
Pharmaceutical (36)
Pharmacy benefit managers (17)
Phase I (20805)
Phase II (29337)
Phase III (21866)
Pipeline (1142)
Policy (146)
Postmarket research (2906)
Preclinical (8988)
Press Release (68)
Prostate cancer (103)
Psychedelics (37)
Radiopharmaceuticals (258)
Rare diseases (397)
Real estate (6386)
Recruiting (69)
Regulatory (22856)
Reports (40)
Research institute (2575)
Resumes & cover letters (467)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (75)
Series A (137)
Series B (84)
Service/supplier (10)
Sickle cell disease (54)
Southern California (2170)
Special edition (15)
Spinal muscular atrophy (156)
Sponsored (32)
Startups (3592)
State (1)
Stomach cancer (12)
Supply chain (67)
Tariffs (28)
The Weekly (62)
United States (22146)
Vaccines (721)
Venture capitalists (40)
Weight loss (245)
Women's health (36)
Worklife (19)
Date
Last 7 days (655)
Last 30 days (2389)
Last 365 days (32697)
2025 (10066)
2024 (34992)
2023 (39552)
2022 (50617)
2021 (55660)
2020 (54659)
2019 (48549)
2018 (36901)
2017 (33555)
2016 (33457)
2015 (39143)
2014 (32845)
2013 (29149)
2012 (30590)
2011 (30451)
2010 (29294)
Location
Africa (1007)
Alabama (57)
Alaska (7)
Arizona (203)
Arkansas (14)
Asia (42309)
Australia (7472)
California (5686)
Canada (1948)
China (525)
Colorado (261)
Connecticut (278)
Delaware (139)
Europe (97165)
Florida (870)
Georgia (210)
Idaho (58)
Illinois (556)
India (27)
Indiana (305)
Iowa (9)
Japan (158)
Kansas (104)
Kentucky (25)
Louisiana (11)
Maine (64)
Maryland (873)
Massachusetts (4275)
Michigan (219)
Minnesota (367)
Mississippi (2)
Missouri (88)
Montana (31)
Nebraska (23)
Nevada (58)
New Hampshire (62)
New Jersey (1696)
New Mexico (30)
New York (1698)
North Carolina (992)
North Dakota (7)
Northern California (2477)
Ohio (196)
Oklahoma (15)
Oregon (35)
Pennsylvania (1274)
Puerto Rico (10)
Rhode Island (31)
South America (1342)
South Carolina (21)
South Dakota (1)
Southern California (2170)
Tennessee (102)
Texas (868)
Utah (181)
Virginia (146)
Washington D.C. (62)
Washington State (540)
West Virginia (3)
Wisconsin (56)
721,011 Results for "national institute of neurological disorders and stroke".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)
Battelle, Andelyn Biosciences, Inc. , and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to manufacture suspension process gene therapy for the transformative treatment of Aspartylglucosaminuria (AGU).
November 20, 2023
·
4 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
NIH awards Feinstein Institutes $2 million to study impact of heat, stroke on people with Alzheimer’s disease
April 16, 2025
·
3 min read
Business
Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
Virpax ® Pharmaceuticals, Inc. today announced that it has entered into a cooperative research and development agreement (CRADA) with the National Institute of Neurological Disorders and Stroke (NINDS).
June 21, 2023
·
6 min read
Approvals
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
TNKase is the first stroke drug to win FDA approval in nearly three decades.
March 4, 2025
·
2 min read
·
Tristan Manalac
Business
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
The team of Battelle, AmplifyBio and Andelyn Biosciences has won a seat on an eight-year, $149 million indefinite delivery, indefinite quantity (IDIQ) contract vehicle for the National Institute of Neurological Disorders and Stroke.
January 6, 2023
·
4 min read
Business
NexImmune Announces Research Collaboration with National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)
NexImmune, Inc. today announced a collaboration with the National Institute of Neurological Disorders and Stroke (NINDS), a division of the U.S. National Institutes of Health (NIH).
October 6, 2022
·
5 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
Press Releases
Ontario Brain Institute partners with EpiSign to advance diagnosis of rare genetic disorders
March 26, 2025
·
3 min read
Neuroscience
Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 72,102
Next
